BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28921662)

  • 21. Correspondence regarding: Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome by Bhatt et al.
    O'Rourke MF; Adji A; Weber T
    Vasc Med; 2016 Feb; 21(1):70. PubMed ID: 26669325
    [No Abstract]   [Full Text] [Related]  

  • 22. Does β selectivity really affect outcome?
    Wicker JF; Bronheim D
    Anesthesiology; 2014 May; 120(5):1286-7. PubMed ID: 24755797
    [No Abstract]   [Full Text] [Related]  

  • 23. Bradyarrhythmia after treatment with atenolol and mirtazapine in a cat with hypertrophic cardiomyopathy.
    Oricco S; Quintavalla C; Apolloni I; Crosara S
    J Vet Cardiol; 2024 Jun; 53():72-76. PubMed ID: 38735230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of beta antagonist treatment for infantile hemangioma.
    Phillips CB; Pacha O; Biliciler-Denkta G; Hebert AA
    J Drugs Dermatol; 2012 Jul; 11(7):826-9. PubMed ID: 22777223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In reply.
    Ashes C; Judelman S; Wijeysundera D; Tait G; Hare GM; Mazer CD; Beattie WS
    Anesthesiology; 2014 May; 120(5):1287-8. PubMed ID: 24755798
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.'.
    Raju A; Khundkar R
    J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):412-3. PubMed ID: 24200706
    [No Abstract]   [Full Text] [Related]  

  • 27. Response from the authors of 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group'.
    de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
    J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):411-2. PubMed ID: 24238766
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular disease: Questioning the effect of β-blockers on vascular stiffness.
    Szeto CC; Li PK
    Nat Rev Nephrol; 2015 Aug; 11(8):447-8. PubMed ID: 25941061
    [No Abstract]   [Full Text] [Related]  

  • 29. Atenolol as treatment for hepatic hemangiomas in a premature infant.
    Der Sarkissian S; Ge L; Sun HY; Chen MKY; Sebaratnam DF
    Pediatr Neonatol; 2022 May; 63(3):317-318. PubMed ID: 35219642
    [No Abstract]   [Full Text] [Related]  

  • 30. Keratoconjunctivitis sicca exacerbation in a dog treated with systemic atenolol.
    Barsotti G; Vezzosi T
    J Small Anim Pract; 2016 Jul; 57(7):379-81. PubMed ID: 27071733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient safety: anesthesiology contributions and supplements to the American Society of Anesthesiologists' Annual Meeting.
    Eisenach JC
    Anesthesiology; 2013 Oct; 119(4):745-6. PubMed ID: 23924681
    [No Abstract]   [Full Text] [Related]  

  • 33. Reducing arterial stiffness in CKD: revising the paradigms.
    Chirinos JA; Townsend RR
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):547-50. PubMed ID: 25784173
    [No Abstract]   [Full Text] [Related]  

  • 34. Atenolol prevents the formation of expansive hematoma after rhytidoplasty.
    Moreira AC; Moreira M; Gurgel SJ; Moreira YC; Martins ER; Hartmann RC; Fagundes DJ
    Rev Col Bras Cir; 2014; 41(5):305-10. PubMed ID: 25467093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of propranolol for infantile hemangiomas.
    Küpeli S
    Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of propranolol therapy in Moroccan children with infantile hemangioma.
    Lahrichi A; Hali F; Baline K; Fatoiki FZE; Chiheb S; Khadir K
    Arch Pediatr; 2018 Nov; 25(8):449-451. PubMed ID: 30361087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
    Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
    Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks?
    Self TH; Wallace JL; Soberman JE
    J Asthma; 2012 Nov; 49(9):947-51. PubMed ID: 22974249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying iatrogenic depression using confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in patients prescribed a verapamil-sustained-release-led or atenolol-led hypertension treatment strategy.
    Wilson DL; Ried LD
    Res Social Adm Pharm; 2012; 8(4):309-20. PubMed ID: 22133650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.